Scancell Employee Directory
Biotechnology ResearchEngland, United Kingdom51-200 Employees
Scancell, a clinical-stage biotechnology company based in Oxford, England, concentrates on immunotherapy approaches for cancer. It seeks to address substantial and ongoing unmet medical needs by pursuing treatments that aim for durable responses without compromising safety. The company has built a portfolio that includes ready-to-use vaccines and tumour-specific monoclonal antibodies designed to mobilize immune cells or deliver therapeutic agents. Its vaccine programs, SCOPE and ModiFY, have progressed in Phase 2 trials, with evidence of long-term survival in metastatic melanoma and activity across a broad range of solid tumors. The business targets patients with difficult-to-treat cancers, seeking therapies that balance effectiveness with safety within the immunotherapy landscape. Based in Oxford, Scancell operates as a mid-sized biotechnology firm within the UK life sciences ecosystem.
1-888-653-2347 
support@leadiq.com 
